Diagnostic values of edema-sensitive T2-weighted imaging, TSE T1-weighted early contrast-enhanced imaging, late gadolinium enhancement, and the Lake Louise criteria in assessing acute myocarditis: A single-center cardiac magnetic resonance study

Diagnostic values of edema-sensitive T2-weighted imaging, TSE T1-weighted early contrast-enhanced imaging, late gadolinium enhancement, and the Lake Louise criteria in assessing acute myocarditis: A single-center cardiac magnetic resonance study

Objective: The aim of this study was to evaluate the diagnostic accuracy of the Lake Louise consensus criteria using cardiac magnetic resonance (CMR) imaging assessment of edema, hyperemia, and late gadolinium enhancement (LGE) in the diagnostic determination of acute myocarditis. Methods: A total o...

Full description

Bibliographic Details
Main Authors:	Deniz Alis, Arda Güler, Ozan Aşmakutlu, Begüm Uygur, Seyhan Ördekçi
Format:	Article
Language:	English
Published:	KARE Publishing 2020-04-01
Series:	Türk Kardiyoloji Derneği Arşivi
Subjects:	acute myocarditis cardiac magnetic resonance; edema; hyperemia; late gadolinium enhancement.
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-67467

Similar Items

Quantitative Assessment of Late Gadolinium Enhancement and Edema at Cardiac Magnetic Resonance in Low-Risk Myocarditis Patients
by: Caterina Beatrice Monti, et al.
Published: (2022-04-01)

Late gadolinium enhancement characteristics in giant cell myocarditis
by: Shujuan Yang, et al.
Published: (2021-06-01)

Gadolinium retention after contrast-enhanced magnetic resonance imaging: A narrative review
by: Afnan Fahd Al-Muhanna
Published: (2022-01-01)

Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction
by: Nicolò Ghionzoli, et al.
Published: (2022-10-01)

The pattern of late gadolinium enhancement by cardiac MRI in fulminant myocarditis and its prognostic implication: a two-year follow-up study
by: Luying Jiang, et al.
Published: (2023-06-01)

The Association between the Extent of Late Gadolinium Enhancement and Diastolic Dysfunction in Hypertrophic Cardiomyopathy
by: Deniz Alis, et al.
Published: (2021-04-01)

Toxicity associated with gadolinium-based contrast-enhanced examinations
by: Silvia Maria Lattanzio
Published: (2021-05-01)

Case Report: Disappearance of Late Gadolinium Enhancement and Full Functional Recovery in a Young Patient With SARS-CoV-2 Vaccine-Related Myocarditis
by: Grigorios Korosoglou, et al.
Published: (2022-03-01)

Gadolinium in Medical Imaging—Usefulness, Toxic Reactions and Possible Countermeasures—A Review
by: Lennart Blomqvist, et al.
Published: (2022-05-01)

Prognosis evaluation of chronic inflammatory cardiomyopathy with ring‐like late gadolinium enhancement
by: Hui Wang, et al.
Published: (2023-06-01)

Detection of Active Plaques in Multiple Sclerosis using 3 and 12 Directional Diffusion-weighted Imaging: Comparison with Gadolinium-enhanced MR Imaging
by: G H Meftahi, et al.
Published: (2020-12-01)

Myocardial fibrosis detected with Gadolinium Delayed Enhancement in Cardiac Magnetic Resonance Imaging and Ventriculoarterial Coupling alterations in patients with Acute Myocarditis
by: Christina Chrysohoou, MD, et al.
Published: (2016-11-01)

Improving acute demyelinating lesion detection: which T1-weighted magnetic resonance acquisition is more sensitive to gadolinium enhancement?
by: Lázaro Luiz Faria do AMARAL, et al.

Characteristics and Prognosis of a Contemporary Cohort with Myocardial Infarction with Non-Obstructed Coronary Arteries (MINOCA) Presenting Different Patterns of Late Gadolinium Enhancements in Cardiac Magnetic Resonance Imaging
by: Valentina Bucciarelli, et al.
Published: (2023-03-01)

Predictors of Mortality in Patients With Biopsy‐Proven Viral Myocarditis: 10‐Year Outcome Data
by: Simon Greulich, et al.
Published: (2020-08-01)

Gadolinium-Based Paramagnetic Relaxation Enhancement Agent Enhances Sensitivity for NUS Multidimensional NMR-Based Metabolomics
by: Chandrashekhar Honrao, et al.
Published: (2021-08-01)

Utility of late gadolinium enhancement on magnetic resonance imaging in hypertrophic cardiomyopathy patients in an Indian cohort
by: Harikrishnan Gangadharakaimal, et al.
Published: (2023-09-01)

Unique pattern of late gadolinium enhancement on cardiac magnetic resonance imaging in Duchenne muscular dystrophy
by: Madhusudan Ganigara, et al.
Published: (2016-01-01)

The Influence of Late Gadolinium Enhancement Cardiac Magnetic Resonance Image Analysis Imprecision on Myocardial Damage Quantification in Patients with Myocarditis: A Pilot Study
by: Lana Kralj, et al.
Published: (2023-12-01)

Toxicity Mechanisms of Gadolinium and Gadolinium-Based Contrast Agents—A Review
by: Susana Coimbra, et al.
Published: (2024-04-01)

Silent myocarditis in systemic sclerosis detected by cardiovascular magnetic resonance using Lake Louise criteria
by: Sophie Mavrogeni, et al.
Published: (2017-07-01)

Diffusion Weighted Imaging versus Contrast- enhanced T1-weighted Imaging Sequences in Inflammatory Demyelinating Diseases of Brain: A Cross-sectional Study
by: KR Manohar Kumar, et al.
Published: (2022-10-01)

Clinical and Cardiovascular Magnetic Resonance Predictors of Early and Long-Term Clinical Outcome in Acute Myocarditis
by: Yohann Bohbot, et al.
Published: (2022-04-01)

Eosinophilic myocarditis: Case report and brief review of the literature
by: Thomas Fakadej, BS, et al.
Published: (2023-01-01)

Assessment of gadolinium deposition in the brain tissue of pediatric and adult congenital heart disease patients after contrast enhanced cardiovascular magnetic resonance
by: Neil Zaki, et al.
Published: (2020-12-01)

Attenuation of gadolinium enhancement in pituitary gland on magnetic resonance imaging of patients with pediatric growth hormone deficiency
by: Mariko Doai, et al.
Published: (2023-11-01)

Incidental MRI Findings of Acute Gadolinium Hypersensitivity
by: C. Amene, et al.
Published: (2012-04-01)

Synthesis of Organosilicon Ligands for Europium (III) and Gadolinium (III) as Potential Imaging Agents
by: James I. Bruce, et al.
Published: (2020-09-01)

Gadolinium Deposition in the Brain and Body
by: Aart J. van der Molen
Published: (2019-11-01)

Cardiac Magnetic Resonance Relaxometry Parameters, Late Gadolinium Enhancement, and Feature-Tracking Myocardial Longitudinal Strain in Patients Recovered from COVID-19
by: Jadwiga Fijalkowska, et al.
Published: (2023-06-01)

Junctional ectopic tachycardia secondary to myocarditis associated with sudden cardiac arrest
by: Michael E.A. Cunningham, MD, et al.
Published: (2017-02-01)

Influence of Synthesis Conditions on Gadolinium-Substituted Tricalcium Phosphate Ceramics and Its Physicochemical, Biological, and Antibacterial Properties
by: Inna V. Fadeeva, et al.
Published: (2022-03-01)

Cardiac magnetic resonance‐based layer‐specific strain in immune checkpoint inhibitor‐associated myocarditis
by: Zheng Li, et al.
Published: (2024-04-01)

Impact of aortic stiffness by velocity-encoded magnetic resonance imaging on late gadolinium enhancement to predict cardiovascular events
by: Yodying Kaolawanich, et al.
Published: (2020-10-01)

Neodymium-Doped Gadolinium Compounds as Infrared Emitters for Multimodal Imaging
by: Maxime Delaey, et al.
Published: (2023-09-01)

Role of smoking in the evolution of cardiovascular magnetic resonance and laboratory findings of acute myocarditis
by: Efstathios Detorakis, et al.
Published: (2020-01-01)

T(1) mapping for the diagnosis of acute myocarditis using CMR: comparison to T2-weighted and late gadolinium enhanced imaging.
by: Ferreira, V, et al.
Published: (2013)

T1 Mapping for the diagnosis of acute myocarditis using CMR: Comparison to T2-Weighted and late gadolinium enhanced imaging
by: Ferreira, V, et al.
Published: (2013)

Contrast‐Enhanced Cardiac Magnetic Resonance Imaging With a Manganese‐Based Alternative to Gadolinium for Tissue Characterization of Acute Myocardial Infarction
by: Benjamin P. Bonner, et al.
Published: (2023-04-01)

Image quality of late gadolinium enhancement in cardiac magnetic resonance with different doses of contrast material in patients with chronic myocardial infarction
by: Caterina Beatrice Monti, et al.
Published: (2020-04-01)